Stemtech (OTCQB:STEK), a global leader in stem cell nutrition, is proud to announce strategic leadership appointments and the upcoming launch of its highly anticipated StemPets™ product line. Committed to enhancing health for individuals and pets alike, Stemtech continues to drive innovation in the wellness space.
StemPets™: A Game Changer in Pet Health
Stemtech is set to launch StemPets in early Q2 of 2025, marking its entry into the booming pet healthcare sector, projected to exceed $303 billion by 2027.
John W. Meyer, President & COO of Stemtech said:
“We are excited to bring the power of stem cell nutrition to pets, offering a breakthrough solution for pet owners. StemPets is a game changer in pet care, uniquely positioning us to capture market growth with science-backed products.”
Strategic Leadership Appointments
To drive global expansion, Stemtech welcomes key executives:
Alejandro Carrillo, Vice President of Global Operations, will oversee manufacturing, inventory, and expansion management.
Srilakshmi Vadlapatla, Global Accounts Manager and future CFO, will lead financial strategy, bringing vast experience in international finance.
Manuel Ramirez Garcia, Director of Global Sales & Field Development, will spearhead global sales strategy and market expansion, leveraging over 20 years of experience.
“We are thrilled to have Srilakshmi and Manuel join our leadership team and Alex in his new